Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25
Macquarie Initiates Coverage On Privia Health Gr With Outperform Rating, Announces Price Target of $25
麥格理啓動了對Privia Health Gr的覆蓋,給予其優於大盤的評級,並宣佈目標價爲25美元。
Macquarie analyst Tao Qiu initiates coverage on Privia Health Gr (NASDAQ:PRVA) with a Outperform rating and announces Price Target of $25.
麥格理的分析師裘濤對Privia Health Gr(納斯達克:PRVA)首次覆蓋,給予超越市場表現評級,併發布25美元的目標價。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。